Inventor · disambiguated record
Russell D. Cink
Also filed as: CINK RUSSELL D · CINK RUSSELL DREW
17 granted patents·7 pending applications·241 citations·filing 2000–2020
92Inventor score
Top patents by PatentIndex Score
24 records- 0195US6437106B1Process for preparing 6-o-substituted erythromycin derivativesABBOTT LAB·Filed 2000·Granted Aug 20, 2002·161 cites·30 claims
- 0293US9809576B1Synthetic route to anti-viral agentsABBVIE INC·Filed 2015·Granted Nov 7, 2017·14 cites·2 claims
- 0388US8487116B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorGOMTSYAN ARTHUR R·Filed 2011·Granted Jul 16, 2013·5 cites·14 claims
- 0487US8071762B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorGOMTSYAN ARTHUR R·Filed 2008·Granted Dec 6, 2011·5 cites·5 claims
- 0586US10077256B2Synthetic route to anti-viral agentsABBVIE INC·Filed 2017·Granted Sep 18, 2018·2 cites·14 claims
- 0685US7378414B2Anti-infective agentsABBOTT LAB·Filed 2004·Granted May 27, 2008·17 cites·30 claims
- 0785US7259186B2Salts of fenofibric acid and pharmaceutical formulations thereofABBOTT LAB·Filed 2004·Granted Aug 21, 2007·22 cites·15 claims
- 0878US7375126B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2004·Granted May 20, 2008·9 cites·8 claims
- 0973US2020095230A1Synthetic route to anti-viral agentsABBVIE INC·Filed 2019·Application pending·0 cites
- 1070US10442792B2Synthetic route to anti-viral agentsABBVIE INC·Filed 2018·Granted Oct 15, 2019·0 cites·30 claims
- 1169US7521439B2Glucocorticoid receptor ligands for the treatment of metabolic disordersKAROBIO AB·Filed 2006·Granted Apr 21, 2009·1 cites·12 claims
- 1268US6797721B2Phorboxazole derivatives for treating cancerPARKER HUGHES INST·Filed 2002·Granted Sep 28, 2004·4 cites·11 claims
- 1365US2009263477A1Salts of fenofibric acid and pharmaceutical formulations thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 1460US10689675B2Enzymatic processes for the preparation of (±)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (±)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acidABBVIE INC·Filed 2018·Granted Jun 23, 2020·0 cites·11 claims
- 1560US2021087592A1Enzymatic processes for the preparation of (±)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (±)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acidABBVIE INC·Filed 2020·Application pending·0 cites
- 1659US2008051411A1Salts of Fenofibric Acid and Pharmaceutical Formulations ThereofCINK RUSSELL D·Filed 2007·Application pending·0 cites
- 1757US2014187561A1Salts of fenofibric acid and pharmaceutical formulations thereofABBVIE INC·Filed 2013·Application pending·0 cites
- 1856US7141559B2Glucocorticoid receptor ligands for the treatment of metabolic disordersKAROBIO AB·Filed 2003·Granted Nov 28, 2006·1 cites·21 claims
- 1955US7538105B2Anti-infective agentsABBOTT LAB·Filed 2008·Granted May 26, 2009·0 cites·19 claims
- 2052US9493506B2Macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2014·Granted Nov 15, 2016·0 cites·21 claims
- 2151US2005119322A1Phorboxazole derivatives for treating cancerUNIV MINNESOTA·Filed 2004·Application pending·0 cites
- 2249US2013018101A1Salts of fenofibric acid and pharmaceutical formulations thereofCINK RUSSELL DREW·Filed 2012·Application pending·0 cites
- 2345US8124129B2Crystalline form of the compound A-348441CINK RUSSELL DREW·Filed 2006·Granted Feb 28, 2012·0 cites·18 claims
- 2438US8748374B2Macrocyclic hepatitis C serine protease inhibitorsCHEN HUI-JU·Filed 2011·Granted Jun 10, 2014·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →